Related Experiment Video
Updated: Aug 6, 2026
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation
Dianzhe Tian1,2, Xinshi Li3, Zuyi Yang2,4,5
1Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract:
Cancer remains a major global health challenge, and traditional treatments often involve significant toxicity and limited benefits for patients with advanced-stage disease. mRNA vaccines have recently emerged as a promising approach in cancer immunotherapy due to their flexibility in design, rapid production, and suitability for personalized treatment. This review summarizes the molecular basis, main classifications, and mechanisms of action of mRNA vaccines for cancer therapy and systematically discusses progress in strategies for delivering tumor-specific antigens, tumor-associated antigens, and immunomodulatory factors. Special attention is given to advances in delivery technologies, especially lipid nanoparticle (LNP) systems, and their potential applications across various cancers. We suggest that the effectiveness of mRNA cancer vaccines depends not only on selecting the right antigens but also on delivery methods that modulate the immune response and reshape the tumor microenvironment. Melanoma is a prime candidate for prioritizing the research and development of mRNA cancer vaccines, given the current clinical landscape. Furthermore, major challenges that continue to limit progress include insufficient stability, suboptimal delivery efficiency, uncontrolled immunogenicity, and the difficulty of overcoming tumor heterogeneity. This review aims to serve as a useful reference for further development and clinical translation of mRNA cancer vaccines.
Insights
Messenger RNA (mRNA) cancer vaccines offer a flexible and personalized immunotherapy approach. Optimizing antigen delivery and immune response modulation is key to overcoming challenges like stability and tumor heterogeneity for effective cancer treatment.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer immunotherapy faces challenges with traditional treatments, necessitating novel approaches.
- Messenger RNA (mRNA) vaccines present a flexible, rapidly producible, and personalized strategy for cancer therapy.
- mRNA vaccines leverage the immune system to target cancer cells, offering a promising alternative.
Purpose of the Study:
- To review the molecular basis, classifications, and mechanisms of mRNA cancer vaccines.
- To discuss advancements in delivering tumor antigens and immunomodulatory factors.
- To highlight the role of delivery technologies, particularly lipid nanoparticles (LNPs), in mRNA cancer vaccine efficacy.
Main Methods:
- Systematic review of current literature on mRNA cancer vaccine technology.
- Analysis of molecular mechanisms underlying mRNA vaccine action in cancer.
- Evaluation of delivery strategies and their impact on immune response and tumor microenvironment.
Main Results:
- mRNA vaccines demonstrate potential for personalized cancer treatment through tailored antigen selection.
- Lipid nanoparticle (LNP) systems are crucial for efficient delivery and immune modulation.
- Melanoma is identified as a key area for prioritizing mRNA cancer vaccine development.
Conclusions:
- Effective mRNA cancer vaccines require optimized antigen selection and delivery methods to modulate immunity and the tumor microenvironment.
- Overcoming challenges such as stability, delivery efficiency, immunogenicity, and tumor heterogeneity is critical for clinical translation.
- Continued research and development are essential for advancing mRNA cancer vaccines towards widespread clinical application.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
01:29Microorganisms in Medicine and Therapeutics
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...